You are here

Leadership

 

Turnover among hospital CEOs was 18 percent in 2016, the same as in the prior two years, but remains among “the highest rates calculated in the last two decades,” according to the American College of Healthcare Executives (ACHE).

The Federation of American Hospitals (FAH) has largely remained silent on ongoing Republican-led efforts to repeal and replace the Affordable Care Act (ACA), including the recently passed American Health Care Act (AHCA). The group has now weighed in on the legislative battle, offering its “core principles” to Senate Finance Committee Chairman Orrin Hatch, R-Utah.

Healthcare executives believe the shift to value-based care and risk-sharing models will be transforming the industry within the next few years, according to a survey published by Lazard.

The U.S. Senate confirmed Scott Gottlieb, MD, as the new commissioner of the Food and Drug Administration (FDA), bringing the former deputy commissioner back to lead the agency. 

The 2017 meeting of the American Hospital Association (AHA) led off with an unsurprising topic: the legislation to repeal and replace the Affordable Care Act (ACA).  

 

Recent Headlines

Hospital CEO turnover remains high in 2016

Turnover among hospital CEOs was 18 percent in 2016, the same as in the prior two years, but remains among “the highest rates calculated in the last two decades,” according to the American College of Healthcare Executives (ACHE).

5 things for-profit hospitals want from ACA repeal-and-replace

The Federation of American Hospitals (FAH) has largely remained silent on ongoing Republican-led efforts to repeal and replace the Affordable Care Act (ACA), including the recently passed American Health Care Act (AHCA). The group has now weighed in on the legislative battle, offering its “core principles” to Senate Finance Committee Chairman Orrin Hatch, R-Utah.

C-suite expects to reach value-based care tipping point by 2020

Healthcare executives believe the shift to value-based care and risk-sharing models will be transforming the industry within the next few years, according to a survey published by Lazard.

Ohio State Wexner CEO resigns after ‘no confidence’ letter from physicians

Sheldon Retchin, MD, has stepped down as CEO of Ohio State Wexner Medical Center after physicians and faculty complained about his management style in letters to university leaders, alleging he disrespected the hospital’s mission and set “unrealistic” goals on clinical and research initiatives. 

Scott Gottlieb confirmed as FDA commissioner

The U.S. Senate confirmed Scott Gottlieb, MD, as the new commissioner of the Food and Drug Administration (FDA), bringing the former deputy commissioner back to lead the agency. 

ACA, healthcare legislation hot topics at AHA meeting

The 2017 meeting of the American Hospital Association (AHA) led off with an unsurprising topic: the legislation to repeal and replace the Affordable Care Act (ACA).  

Molina Healthcare fires CEO and CFO, sons of company’s founder

J. Mario Molina, MD, and John Molina have been ousted as CEO and CFO, respectively, of the company started by their father over “disappointing financial performance.”

Geisinger CEO David Feinberg: Healthcare ‘is ripe to be disrupted’

Providers and payors are broadening their definition of care delivery to address issues like housing and nutrition programs, though they may not agree on how well-equipped the healthcare industry is to solve these problems.

Cleveland Clinic CEO Toby Cosgrove stepping down by end of 2017

After 13 years in charge of the Cleveland Clinic, Toby Cosgrove, MD, has announced he’ll be transitioning out of his CEO role by the end of the year.

5 things to know about execs’ pessimistic takes on healthcare under Trump

Healthcare executives and clinical leaders predict “no clear winners, only losers” when asked to assess President Donald Trump’s impact on their industry in a survey conducted by the New England Journal of Medicine

Pages